News

NIH honors Providence scientitst with $1.6 million immunotherapy research grant

June 13, 2014

In a significant show of support for immunotherapy research in the treatment of cancer, the National Institutes of Health has awarded a $1.6...

Providence Cancer Center research intern experienced disease firsthand

August 29, 2013

Ellen Patterson spent her summer as a cancer research intern at Providence Cancer Center after successfully battling ovarian cancer at 15.

New immunotherapy treatment shows great promise for patients fighting B-cell non-Hodgkin's lymphoma

May 16, 2013

Finding effective treatments for the various types of cancer – it’s the goal of researchers around the world, and right here in Portland. Now Providence Cancer Center is the first site in the nation to test a new immunotherapy treatment that’s showing great promise for patients fighting B-cell non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Providence cancer research gets boost from Fred Meyer shoppers and employees

April 02, 2013

The donation is a result of the store chain's third quarter employee giving campaign and all the coins collected in the checkout lines at Portland area locations.

Innovative treatment for leukemia used to treat young Redmond girl

March 29, 2013

Dr. Walter Urba, director of cancer research for Providence's Robert W. Franz Cancer Research Center, comments on experimental immunotherapy treatment in this article from The Bend Bulletin.

NIH grant furthers promising metastatic melanoma clinical trials for Providence Cancer Center patients

March 15, 2013

Patients with advanced melanoma are getting a boost from work being done at Providence, thanks to a grant from the National Institutes of Health.

Portland Business Journal reports Providence's cancer team making strides

March 11, 2013

In the past 20 years, Providence has contributed to several significant breakthroughs in cancer research.

Early-phase clinical trials open new opportunities

January 16, 2013

Providence's involvement with the International Immuno-Oncology Network, along with other early-phase studies, is broadening treatment options for patients with advanced cancers.

A month of giving adds up as Safeway battles cancer with Providence

January 14, 2013

Funds from Safeway's "round up" at the checkout counters will be divided among four areas of breast cancer research at Providence.

Providence cancer research laboratory receives major grants

December 06, 2012

Research scientist Keith Bahjat, Ph.D., recently received two grants supporting work on immunotherapy.

Providence Cancer Center recognized for commitment to quality and excellence

September 28, 2012

Providence is the only cancer facility in Oregon to receive QOPI certification.

News from China on new transformational approach in oncology

September 27, 2012

Bernie Fox, Ph.D., speaks at annual meeting in China about a new approach to determine immune response to tumors.

eOncology Report: Treating HPV-related cancers

August 29, 2012

Read about this and more in Providence Cancer Center's summer clinical newsletter.

Research offers great hope for advanced melanoma patients

June 06, 2012

Providence Cancer Center researchers study a unique approach, combining radiation and immunotherapy treatments.

Immune therapy may yield long-lasting treatment for many cancers

June 04, 2012

"There is still a long road ahead, but now it's lined with some successes," says Walter Urba, M.D., Ph.D.

Pennies, nickels and dimes add up to $500,000 as Safeway customers and employees help Providence battle breast cancer

May 08, 2012

Safeway customers and employees in Oregon and Southwest Washington raised $500,000 for breast cancer awareness, treatment and research at Providence.

Cancer research news

April 26, 2012

Read the latest highlights on our researchers.

Komen Catalyst Grant Awarded To Providence Cancer Center for Cell Study

April 26, 2012

Providence Cancer Center researcher Michael Gough, Ph.D., has received a Career Catalyst Research Grant from Susan G. Komen for the Cure to study the possibility of ending metastatic cancer.

Providence cancer research gets a boost with MedImmune agreement

December 02, 2011

The biotech company will fund further OX40 research developed by Providence scientists.

Providence cancer researcher earns two-year award

November 07, 2011

William Redmond, Ph.D., received the 2011 V Scholar Award from The V Foundation for Cancer Research.

Providence cancer drug trial wins FDA approval

April 11, 2011

Ipilimumab is the first drug shown to extend survival in patients with late-stage melanoma.